Stormont Vail Health Partners with Omnicell to Enhance Medication Management Strategy
New solutions to help improve efficiency and safety in patient care areas and create more autonomous process for in-house sterile compounding in pharmacy
MOUNTAIN VIEW, Calif., March 7, 2019 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL) today announced that Stormont Vail Health has selected Omnicell's automated medication management platform to help enhance safety and efficiency in the central pharmacy and patient care areas. The health system will be implementing IV robotics to support an in-house sterile compounding operation, as well as Omnicell® XT Series Automated Dispensing Cabinets to streamline workflows in patient care areas.
With the United States spending $450 billion annually on medication management,1 health systems increasingly need to focus on efficient delivery of healthcare in order to control costs, which has elevated the strategic importance of medication management. To support this objective, Omnicell is building on its vision of an Autonomous Pharmacy in which manual, error-prone activities are replaced by efficient, automated processes—ideally with zero errors. Health systems like Stormont Vail Health are leveraging Omnicell's automated medication management infrastructure to help improve patient care, reduce errors, enhance safety, and identify new opportunities for growth.
Stormont Vail is implementing Omnicell's i.v.STATIONTM Non-hazardous Compounding Robots to drive improvements in their sterile compounding operation. By fully automating the IV compounding process, i.v.STATION helps hospitals and health systems to further enhance patient safety, improve therapy, reduce cost, and facilitate compliance in the IV room.
"We are continually looking for opportunities to improve processes that support delivery of the best care for our patients," said Sridevi Donepudi, MD, vice president and chief medical quality officer. "By leveraging IV automation for sterile compounding, we can drive down costs and help ensure the safest approach to IV preparation."
Omnicell's XT Series Automated Medication Dispensing Cabinets will also be installed at Stormont Vail Health to help improve workflow efficiency for both nursing and pharmacy while helping to increase medication accountability and patient safety.
"We're committed to strategic partnerships with customers like Stormont Vail Health to deliver on our vision of an autonomous approach to medication management," said Scott Seidelmann, executive vice president and chief commercial officer at Omnicell. "Our automation solutions and services will support their needs today, and are designed to grow as healthcare challenges continue to evolve."
About Stormont Vail Health
Stormont Vail Health is a nonprofit integrated health system that has been serving the health care needs of Kansas for more than 130 years. It is composed of Stormont Vail Hospital, a 586-bed acute care hospital, and Cotton O'Neil Clinic, a multi-specialty physician group with more than 500 providers, which includes more than 250 physicians. Nearly 5,100 employees provide care and support services for patients in the hospital and 35 other locations, including the Cotton O'Neil Heart Center, Cancer Center, Diabetes & Endocrinology Center, Digestive Health Center, Pediatrics clinics and 10 regional primary care clinics. Stormont Vail Health is committed to its mission of improving the health of the community by being a national leader in providing compassionate, high-quality and efficient integrated care through collaboration that results in a healthier community.
About Omnicell
Since 1992, Omnicell has been inspired to create safer and more efficient ways to manage medications across all care settings. As a leading provider of solutions across the continuum of care, we offer a path to fully automated medication management infrastructure, powered by a cloud data platform, that supports improved patient care, fewer errors, enhanced safety, and new opportunities for growth.
Our vision for the Autonomous Pharmacy integrates a comprehensive set of solutions powered by the Omnicell Cloud Data Platform across three key areas: Automation – solutions designed to digitize and streamline workflows; Intelligence – actionable insights to better understand medication usage and improve pharmacy supply chain management; and Work – expert services that serve as an extension of pharmacy operations to support improved efficiency, regulatory compliance, and patient outcomes.
Over 5,000 facilities worldwide use Omnicell automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. And more than 40,000 institutional and retail pharmacies across North America and the United Kingdom leverage Omnicell's innovative medication adherence solutions to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.
To learn more about Omnicell and our Autonomous Pharmacy vision, please visit www.omnicell.com.
OMCL-G
Footnotes:
1 IQVIA Institute Report (2018). Medicine Use and Spending in the U.S. A Review of 2017 and Outlook to 2022.
Editor's Notes:
- All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website, omnicell.com.
- Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc.
- All other brand or product names may be trademarks or registered trademarks of their respective companies.
SOURCE Omnicell, Inc.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article